FRED G WEISS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for FRED G WEISS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FRED G WEISS. FRED G WEISS is Director in Allergan plc ($AGN) and Director in Osmotica Pharmaceuticals plc ($OSMT).
Latest Insider Trading Transactions of FRED G WEISS
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2021 | OSMT | Osmotica Pharmaceu ... | WEISS FRED G | Director | Payment of Exercise | F | 2.89 | 18,584 | 53,708 | 62,784 | 81.4 K to 62.8 K (-22.84 %) |
| Jan 26 2021 | OSMT | Osmotica Pharmaceu ... | WEISS FRED G | Director | Payment of Exercise | F | 4.46 | 5,505 | 24,552 | 81,368 | 86.9 K to 81.4 K (-6.34 %) |
| May 22 2020 | OSMT | Osmotica Pharmaceu ... | WEISS FRED G | Director | Payment of Exercise | F | 4.60 | 17,778 | 81,779 | 86,873 | 104.7 K to 86.9 K (-16.99 %) |
| May 22 2020 | OSMT | Osmotica Pharmaceu ... | WEISS FRED G | Director | Grant | A | 0.00 | 38,716 | 0 | 104,651 | 65.9 K to 104.7 K (+58.72 %) |
| Jan 30 2020 | OSMT | Osmotica Pharmaceu ... | WEISS FRED G | Director | Payment of Exercise | F | 7.00 | 5,505 | 38,535 | 65,935 | 71.4 K to 65.9 K (-7.71 %) |
| Jun 19 2019 | OSMT | Osmotica Pharmaceu ... | WEISS FRED G | Director | Grant | A | 0.00 | 37,037 | 0 | 71,440 | 34.4 K to 71.4 K (+107.66 %) |
| Jan 28 2019 | OSMT | Osmotica Pharmaceu ... | WEISS FRED G | Director | Grant | A | 0.00 | 34,403 | 0 | 34,403 | 0 to 34.4 K |
| May 04 2018 | AGN | Allergan plc | WEISS FRED G | Director | Grant | A | 151.07 | 1,985 | 299,874 | 29,675 | 27.7 K to 29.7 K (+7.17 %) |
| May 05 2017 | AGN | Allergan plc | WEISS FRED G | Director | Grant | A | 245.25 | 1,223 | 299,941 | 27,690 | 26.5 K to 27.7 K (+4.62 %) |
| May 05 2017 | AGN | Allergan plc | WEISS FRED G | Director | Payment of Exercise | F | 243.76 | 668 | 162,832 | 26,467 | 27.1 K to 26.5 K (-2.46 %) |
| Aug 09 2016 | AGN | Allergan plc | WEISS FRED G | Director | Grant | A | 248.31 | 201 | 49,910 | 27,135 | 26.9 K to 27.1 K (+0.75 %) |
| May 09 2016 | AGN | Allergan plc | WEISS FRED G | Director | Grant | A | 210.34 | 1,188 | 249,884 | 26,934 | 25.7 K to 26.9 K (+4.61 %) |
| Jun 08 2015 | AGN | Allergan plc | WEISS FRED G | Director | Grant | A | 302.30 | 826 | 249,700 | 25,694 | 24.9 K to 25.7 K (+3.32 %) |
| Jun 08 2015 | AGN | Allergan plc | WEISS FRED G | Director | Payment of Exercise | F | 303.38 | 549 | 166,556 | 24,868 | 25.4 K to 24.9 K (-2.16 %) |
Page: 1